BPH Clinical Trials
Here are the 6 most popular medical studies for bph
Laser Therapy
Thulium Fiber vs MOSES Holmium Laser for Enlarged Prostate
This trial is testing two procedures for benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate. The procedures being tested are transurethral resection of the prostate (TURP) and holmium laser enucleation of the prostate (HoLEP). The study will compare the two procedures in terms of length of hospital stay, intraoperative outcomes, and postoperative outcomes.
Popular filter options for bph trials
Enlarged Prostate Clinical Trials
View 24 Enlarged Prostate medical studies.
Procedure
Traditional vs Top-Down HoLEP for Enlarged Prostate
This trial will compare the two most common types of surgery for treating an enlarged prostate. HoLEP is a newer, less invasive type of surgery that has a shorter hospital stay, but a longer learning curve for surgeons. The "Top-Down" HoLEP technique is a novel technique which offers potential benefits to the Traditional HoLEP procedure, including decreased complexity, a reduced learning curve.
Beta-3 Adrenoceptor Agonist
Mirabegron +1 More for Overactive Bladder
This trial is testing a new OAB treatment combining a β3-adrenoceptor agonist (mirabegron) with an α-blocker. The goal is to see if this is a safe and effective treatment for OAB symptoms in male patients with BPH.
Thermal Therapy
Prolieve for Enlarged Prostate
The primary objective of the post-marketing study is to collect safety and effectiveness data for 5 years on subjects treated with Prolieve®. The collection of 5-year safety information will be used to evaluate the occurrence of any long-term side effects from the treatment. The collection of long-term effectiveness data on subjects treated with Prolieve® will provide information on the long-term effects of treatment and time to re- treatment (any treatment initiated for BPH since Prolieve'" treatment, including a second treatment with Prolieve").
BPH Clinical Trials
View 10 BPH medical studies.
Arm 1: Preoperative and postoperative pelvic floor physical therapy for Stress Incontinence
This trial is looking at a surgical procedure called Holmium laser enucleation of the prostate (HoLEP) that is used to treat an enlarged prostate. The procedure involves removing part of the prostate
Benign Prostatic Hyperplasia Clinical Trials With No Placebo
View 33 benign prostatic hyperplasia medical studies that do not have a placebo group.
Arm 1: Preoperative and postoperative pelvic floor physical therapy for Stress Incontinence
This trial is looking at a surgical procedure called Holmium laser enucleation of the prostate (HoLEP) that is used to treat an enlarged prostate. The procedure involves removing part of the prostate
Procedure
Traditional vs Top-Down HoLEP for Enlarged Prostate
This trial will compare the two most common types of surgery for treating an enlarged prostate. HoLEP is a newer, less invasive type of surgery that has a shorter hospital stay, but a longer learning curve for surgeons. The "Top-Down" HoLEP technique is a novel technique which offers potential benefits to the Traditional HoLEP procedure, including decreased complexity, a reduced learning curve.
View More Bph Trials
See another 15 medical studies focused on bph.
Frequently Asked Questions
Introduction to bph
What are the top hospitals conducting bph research?
When it comes to clinical trials focused on finding new treatments for benign prostatic hyperplasia (BPH), several hospitals across different locations are making significant contributions. In Cleveland, the University Hospitals Cleveland Medical Center leads the way with 1 active BPH trial and a total of 1 trial conducted since recording their first one in 2023. Another facility within the same healthcare system, UH Brainard Medical Building in Lyndhurst, is also actively involved in BPH research with similar numbers of ongoing and completed trials. Similarly, at UH Regional Hospitals - Richmond Campus in Richmond Heights, researchers are conducting an active BPH trial while having completed one previously recorded trial.
Moving outside Ohio, Thunder Bay Regional Health Sciences Centre located in Thunder Bay has made substantial progress as well. This Canadian hospital has an ongoing BPH trial and has successfully conducted one prior study since their initial recorded trial back in 2022. Lastly, the Urology Specialist Group based in Hialeah contributes to advancing our understanding of BPH through its involvement in current and past trials focusing on this condition.
Although these specific hospitals may have limited data available for bph clinical trials at present, they demonstrate a commitment to researching better solutions for patients dealing with this common urological issue characterized by enlargement of the prostate gland that can cause urinary symptoms such as frequent urination or weak urine flow. It's important to recognize that medical advancements take time and require meticulous investigation before reaching conclusive results; nonetheless, the dedication shown by these institutions signifies promising steps towards improving treatment options for those affected by BPH.
Which are the best cities for bph clinical trials?
When it comes to bph clinical trials, several cities show promise in advancing research and treatment options. Thunder Bay, Ontario stands out with 2 active trials examining therapies like the Thulium Fibre Laser and Top-Down HoLEP. Cleveland, Ohio along with its neighboring towns of Lyndhurst and Richmond Heights also contribute to the effort with 1 active trial each focusing on Intravesical Botox injection. Additionally, Hialeah, Florida offers a study on SoracteLite(TM) TPLA for BPH. These cities provide individuals with opportunities to participate in cutting-edge clinical trials that may lead to improved management strategies for benign prostatic hyperplasia (BPH).
Which are the top treatments for bph being explored in clinical trials?
Exciting developments in the field of BPH treatment are emerging from ongoing clinical trials. Prostate Artery Embolization, a procedure that involves blocking blood flow to the prostate to reduce its size, is currently being explored in two active trials and has accumulated five all-time BPH trials since 2014. Another promising option is Intravesical Botox injection, with one active trial underway. Thulium Fibre Laser also shows potential with one active trial investigating its efficacy for BPH treatment. Lastly, SoracteLite(TM) TPLA for BPH has shown promise in one active trial since its introduction in 2020. These innovative treatments offer hope for patients suffering from this common condition and may provide effective alternatives to traditional approaches such as medication or surgery.
What are the most recent clinical trials for bph?
Recent clinical trials have offered new insights and potential treatment options for individuals with benign prostatic hyperplasia (BPH). One noteworthy trial is evaluating a treatment group specifically designed to address the symptoms associated with BPH. Another study focuses on SoracteLite(TM) TPLA, a novel approach that shows promise in managing BPH. These trials highlight the ongoing efforts to improve patient outcomes and quality of life in those affected by this condition.
What bph clinical trials were recently completed?
Two recent clinical trials have explored potential treatments for benign prostatic hyperplasia (BPH). In September 2019, Urovant Sciences GmbH completed a trial investigating the efficacy of Vibegron. Another trial sponsored by the same company concluded in March 2019 and also focused on evaluating Vibegron's effectiveness for BPH. These studies contribute to our understanding of therapeutic options for individuals experiencing this condition and may pave the way for improved management strategies in the future.